Product Information
CLOMIPRAMINE 50 MG CAPSULE is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.2875 per EA under NDC 27241021130. Its NADAC has been published 221 times since Feb 24, 2021.
FDA first approved this application on Oct 2, 2020.
The High Outlier badge above means this manufacturer's average price in the Clomipramine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241021130
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213897FDA Approved
10/2/2020
On Market Since
12/23/2020
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 50 MG CAPSULE has been published 221 times since Feb 24, 2021, and over the history we have for it it has declined 85.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2875 per EA |
|---|---|
| All-time high | $2.0285 (Mar 10, 2021) |
| All-time low | $0.2016 (May 22, 2024) |
| Median price | $0.3717 |
| Average price | $0.6760 |
| Largest weekly change | -56.5% (Nov 23, 2022) |
| Weeks tracked | 221 |
| Tracking since | Feb 24, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-32.1%
5Y
-79.8%
All
-85.8%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 50 MG CAPSULE, manufactured by Ajanta Pharma USA Inc., is $0.2875 per EA (NDC 27241021130), effective May 14, 2025.
How has the price of CLOMIPRAMINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has declined 85.8%. It has been tracked across 221 weekly CMS publications since Feb 24, 2021.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 50 MG CAPSULE?
Since Feb 24, 2021, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has ranged from a low of $0.2016 (May 22, 2024) to a high of $2.0285 (Mar 10, 2021), with a median of $0.3717 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 50 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOMIPRAMINE 50 MG CAPSULE, is $0.2690 per EA — about 6% below CLOMIPRAMINE 50 MG CAPSULE.
Who manufactures CLOMIPRAMINE 50 MG CAPSULE?
CLOMIPRAMINE 50 MG CAPSULE (NDC 27241021130) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.